Eurazeo, Merieux Equity Partners, Ardian and Eximium have sold their stake in Seqens to SK Capital Partners, with a partial reinvestment of the proceeds. Through the sale of their stake in Seqens, Merieux Equity Partners make a 1.8x return on their initial investment, with potential earnouts that could result in a multiple of 2.0x, depending on future company performance.